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Cannabinoid  Receptor  Interacting  Protein  isoform  1b  (CRIP1b)  is known  to  interact  with  the  CB1 receptor.
Alternative  splicing  of the  CNRIP1  gene  produces  CRIP1a  and  CRIP1b  with  a difference  in  the  third  exon
only.  Exons  1 and  2 encode  for a  functional  domain  in  both  proteins.  CRIP1a  is  involved  in regulating  CB1
receptor  internalization,  but  the  function  of CRIP1b  is  not  very  well  characterized.  Since there  are  signif-
icant identities  in  functional  domains  of  these  proteins,  CRIP1b  is  a potential  target  for  drug  discovery.
We  report  here  predicted  structure  of  CRIP1b  followed  by  its interaction  analysis  with  CB1 receptor  by
in-silico  methods  A  number  of  complementary  computational  techniques,  including,  homology  model-
ing,  ab-initio  and  protein  threading,  were  applied  to  generate  three-dimensional  molecular  models  for
CRIP1b.  The  computed  model  of CRIP1b  was  reﬁned,  followed  by  docking  with  C terminus  of CB1 receptor
to  generate  a model  for the  CRIP1b-  CB1 receptor  interaction.  The  structure  of  CRIP1b  obtained  by  homol-
ogy  modelling  using  RHO  GDI-2  as  template  is a  sandwich  fold  structure  having  beta  sheets  connectedoupled receptor by  loops,  similar  to predicted  CRIP1a  structure.  The  best  scoring  reﬁned  model  of CRIP1b  in complex  with
the  CB1 receptor  C terminus  peptide  showed  favourable  polar  interactions.  The  overall  binding  pocket  of
CRIP1b was  found  to  be  overlapping  to that  of CRIP1a.  The  Arg82  and  Cys126  of CRIP1b  are  involved  in
the  majority  of hydrogen  bond  interactions  with  the  CB1 receptor  and  are  possible  key  residues  required
for interactions  between  the  CB1 receptor  and  CRIP1b.
© 2017 Elsevier  Inc.  All  rights  reserved.. Background
Cannabinoid receptors are a family of G protein-coupled recep-
ors that are involved in a wide variety of physiological and
omeostatic processes [1–5]. The two cannabinoid receptors, the
B1 receptor and the CB2 receptor, have been identiﬁed including
ultiple splice variants of CB1in humans [1,2]. The CB1 receptor is
redominantly expressed in brain where it seems to play an impor-
ant role in regulating analgesia, appetite, obesity, learning and
emory, synaptic plasticity, substance abuse disorders, and neuro-
rotection [1,3–5]. The CB2 receptor, in contrast, is found primarily
n peripheral tissue, including tissue associated with immune sys-
Abbreviations: CRIP, cannabinoid receptor interacting protein; FAN, factor
ssociated with neutral sphingomyelinase; GASP, GPCR associated sorting pro-
ein; TIP3P, transferable intermolecular potential with 3 points; THC, tetra-hydro
annabinol; DOPE, discrete optimized protein energy.
∗ Corresponding author.
E-mail address: scowsik@gmail.com (S.M. Cowsik).
ttp://dx.doi.org/10.1016/j.jmgm.2017.09.006
093-3263/© 2017 Elsevier Inc. All rights reserved.tem like spleen and tonsils, and is involved in cannabinoid mediated
immune response [1,2]. Cannabinoid receptors bind and are acti-
vated by the lipid derived endocannabinoid ligands, anandamide
and 2-arachidonoylglycerol [3,4]. CB1 receptor signaling and regu-
lation have assumed increased biomedical signiﬁcance because of
their involvement in variety of physiological disorders and diseases
[3–5].
The CB1 receptor signals mainly through the activation of G
proteins of Gi/o family, and regulates Gi/o-mediated inhibition
of adenylyl cyclase, inhibition of Ca2+ channels, interaction with
receptor tyrosine kinases and non-receptor Src kinases to acti-
vate the Extracellular Signal-Regulated Kinase (ERK1/2), and other
cellular signaling via interactions with Gi/o proteins [1,2]. The
CB1 receptor also interacts with associated proteins that serve
as regulators of cellular signaling (FAN, -arrestins) or recep-
tor trafﬁcking (-arrestins, SGIP1, GASP) [6–8]. In addition, the
CB1receptor also interacts with the cannabinoid receptor interact-
ing protein (CRIP)1a and CRIP1b that function to regulate cellular
signaling and CB1 receptor trafﬁcking [9–16].
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Fig. 1. Schematic outline of the general workﬂow for CRIP1b m
F
e
C
c
aig. 2. The de novo model of peptide from distal tail of CB1 receptor C-terminus.
CRIP1a and CRIP1b are cytosolic proteins that were ﬁrst discov-
red when the Lewis laboratory determined that deletion of the
B1 receptor C-terminal released a tonic inhibition of N-type Ca2+
hannels in neurons, concluding that the C-terminal performed an
uto-inhibition function [5,6]. A yeast two-hybrid screen identiﬁedodeling and its interaction analysis with CB1 receptor.
CRIP1a as a key associated protein [11]. The CRIP1a and CRIP1b
are generated by alternative splicing of CNRIP1 gene located on
chromosome number 2 of the human genome [11]. CRIP1a is a
164-amino acid protein, whereas CRIP1b is a 128-amino acid pro-
tein, and both interact with the CB1 cannabinoid receptor. Although
CRIP1a is conserved among mammals and ﬁsh, the presence of
CRIP1b is limited to primates [11]. CRIP1 proteins have been iden-
tiﬁed immunologically in neurons in the superior cervical ganglion
[11], striatum [17], glutamatergic CA3 pyramidal neurons in the
hippocampus [18,19] and retina [20].
The function of CRIP1a has been clearly established in CB1
receptor selection of Gi/o protein preference and signaling, and
competition for -arrestin to attenuate CB1 receptor internal-
ization [14], whereas the function of CRIP1b is not known
[11]. Exogenous CRIP1a reversed CB1 receptor-mediated tonic
inhibition of Ca2+ currents, whereas CRIP1b could not [11]. CRIP1a-
knockdown clones in the model neuroblastoma N18TG2 cells
exhibited enhanced ERK1/2 phosphorylation efﬁcacy in response
to CP55940 and displayed a leftward shift in CP55940-mediated
inhibition of forskolin-stimulated cAMP accumulation [12,13].
CB1 receptor-mediated Gi3 and Go activation by CP55940 was
attenuated by CRIP1a over-expression, but robustly enhanced in
CRIP1a-knockdown clones. Conversely, CP55940-mediated Gi1 and
Gi2 activation was signiﬁcant enhanced in cells over-expressing
CRIP1a, but not in CRIP1a-knockdown clones [14]. These stud-
ies suggest that endogenous levels of CRIP1a modulate CB1
receptor-mediated signal transduction by facilitating a Gi/o subtype
preference for Gi1 and Gi2, accompanied by an overall suppression
of G protein-mediated signaling in neuronal cells [12,13].
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mig. 3. The secondary structure of CRIP1b predicted by various protocols, the consen
he  beta sheets are represented by ‘E’ and alpha helices by ‘H’.
CRIP1a plays a role in the control of agonist-driven CB1R cell
urface regulation by competing with -arrestins and thereby
ttenuating agonist-mediated internalization [14,15]. CRIP1a over-
xpression attenuated the agonist-induced redistribution of
ndogenous -arrestin to punctae aggregates and subsequent
oss of cell surface CB1receptors. Conversely, CRIP1a knock-down
ugmented agonist-mediated -arrestin redistribution to punc-
ae [14]. Co-immunoprecipitation studies indicated that CRIP1a
ompetes with -arrestin for binding to the CB1 receptor, which
ttenuates the action of -arrestin to mediate CB1R internal-
zation [14]. Peptides mimicking the CB1 receptor C-terminus
ould pull-down CRIP1a from cell extracts and recombinant
RIP1a. Co-immunoprecipitation of CB1 receptor protein com-
lexes demonstrated that distal C-terminal peptides competed for
he CB1 receptor association with CRIP1a [14], demonstrating the
mportance of this domain of the CB1 receptor for CRIP binding
o the CB1 receptor. A similar distal C-terminal sequence found in
he mGlu8a receptor has also been found to interact with CRIP1a,
nd may  sub serve the same functions as for regulation of the CB1
eceptor [16].
Efforts to establish a cellular function for CRIP1b have not
ielded deﬁnitive conclusions. Both CRIP1a and CRIP1b proteins
nteract with the last nine amino acids (S464TDTSAEAL472) of the
istal CB1-C terminus tail of the human CB1 cannabinoid receptor
Fig. 1). The CB1 C-terminus binding is dependent upon a domain
amino acids 34–100) common to both CRIP1a and CRIP1b, as deter-
ined by studies of deletion mutations [11]. CRIP1a and CRIP1bf results was  taken into account to estimate secondary structural content in CRIP1b.
possess distinctly divergent C-terminal domains, such that CRIP1b
has the potential to exhibit functional differences from CRIP1a.
CRIP1 proteins share no sequence homology to other proteins,
so they cannot be categorized into a particular functional family
based upon primary structure. Although recent modeling studies
of CRIP1a by Ahmed et al. [21] revealed a structure containing beta
sheets connected by loops, there is no report on the structure of
CRIP1b so far.
The present study deals with structure prediction of CRIP1b fol-
lowed by analysis of its interaction with a CB1 receptor peptide
by in-silico methods. A number of complementary computational
techniques, including, homology modeling, ab-initio and protein
threading, were applied to generate three dimensional molecular
models for CRIP1b. The computed model of CRIP1b was reﬁned,
followed by docking with the C-terminus of CB1 receptor to gen-
erate a model for the CRIP1b- CB1 receptor interaction. The steps
followed are described in a ﬂow chart given in Fig. 1. The aim of
this study was  the ﬁnding key residues involved in CRIP1b- CB1
receptor interaction in order to provide clues to CRIP1b function.
2. Methods
2.1. CB1 receptor C terminus peptide modelingThe terminal 9-mer sequence from the distal CB1 receptor C-
terminus (S464TDTSAEAL472) was modeled using PEP-Fold [22].
This method, based on structural alphabet SA letters to describe the
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Fig. 4. Sequence alignment of Rho-GDI 2/1DS6 B (template) and CRIP1b sequence.
The  ‘1DS6 b(PDB)’ represents secondary structure of Rho-GDI2 in PDB, and consensus secondary structure represents predicted secondary structure of CRIP1b.
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aFig. 5. The CRIP1b model (A) and its alignme
onformations of four consecutive residues, couples the predicted
eries of SA letters to a greedy algorithm and a coarse-grained force
eld. The most-native clusters of all peptides are ranked in the top
0 generated models [23]..2. CRIP1b modeling and validation
The secondary structure for CRIP1b was predicted by various
lgorithms like HMMSTR, SSPRO4, SSPAL, JNET, SPARROW, SABLE,th the template Rho-GDI 2,cyan colored (B).
NNSSP, NETSURFP, SSP, PSS FINDER, SPINE, and PSIPRED [24–34].
A consensus of secondary structure results was generated by using
GeneSilico Metaserver [35].
The suitable template for the CRIP1b model was selected
by a homology search against Protein Data Bank using Swiss-
Model server, NCBI-Blastp, PDBBLAST, CSBLAST, COMA, Hhblits,
HHSearch, FFAS and Phyre [36–45]. The three dimensional model
was built using MODELLER in Accelrys Discovery Studio 2.5 [46].
Loop reﬁnement protocol was  incorporated to increase the accu-
P. Singh et al. / Journal of Molecular Graphi
Table  1
The DOPE score of CRIP1b models. The models are arranged according to their DOPE
score.
CRIP1b Model DOPE Score
DS model4 −13222.31836
DS model1 −12861.45606
Robetta model1 −12259.22266
Robetta model5 −12102.96289
Robetta model2 −12075.74316
Robetta model3 −11994.18164
Robetta model4 −11134.72266
DS model3 −10764.875
DS model2 −10442.48145
DS model5 −10083.26953
Muster model2 −7846.150391
Muster model9 −7585.559082
Itasser model1 −7320.54834
Muster model4 −7285.194336
Itasser model2 −7151.129883
Muster model3 −7069.747559
Itasser model4 −6522.483887
Muster model7 −6313.573242
Muster model8 −6313.573242
Muster model5 −5812.94873
Muster model6 −5812.632324
Muster model1 −5803.634277
MultiCom model −5381.104004
Itasser model5 −5299.068359
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bMuster model10 −4933.700684
Itasser model3 −1822.536377
acy of the model [47]. The energy minimization was performed
y Conjugate gradient minimization protocol using CHARMM force
eld in Discovery studio [48–50].
Apart from homology modeling, ab-initio and threading meth-
ds using Robetta, Muster and iTasser, were used to calculate a
odel for CRIP1b [51–55]. The Robetta algorithm ﬁrst attempts
omology modeling by searching for conﬁdent homologs from
LAST, PSI-BLAST, FFAS03 or 3D-Jury. If a homolog is not avail-
ble, then the de novo Rosetta fragment insertion method is used
or prediction. Muster and iTasser following a threading algorithm,
ased on fold recognition. The iTasser (Iterative Threading ASSEm-
ly Reﬁnement) follows a hierarchical approach, starting with
OMETS to identify structural templates from the PDB followed
y full-length atomic model construction using iterative template
ragment assembly simulations [53–55]. MUSTER (MUlti-Sources
hreadER) combines sequence proﬁle alignment with multiple
tructural information data to generate sequence-template align-
ents for model prediction [52].
The quality of the models generated by different methods was
nalyzed using Discrete Optimized Protein Energy, or DOPE score.
OPE is an atomic distance-dependent statistical potential from a
ample of native structures, and is extracted from a non-redundant
et of crystallographic structures [56]. The model geometry was
alidated by using Ramachandran plot [57] in Discovery Studio.
he PyMol was employed to aid visualizations, analysis and image
reparation of all the obtained models [58].
.3. Protein-peptide docking
The HADDOCK (High Ambiguity Driven DOCKing) server was
sed for docking CRIP1b-CB1 receptor 9-mer peptide [59–61]. As
he site where C-terminus of CB1 receptor binds exactly on CRIP1b
s not known, the 9-mer peptide was docked with all possible bind-
ng sites with no restriction for unbiased evaluation. The HADDOCK
erforms docking in three stages, starting with randomization of
rientations and rigid-body minimization, and then semi-ﬂexible
imulated annealing in torsion angle space is performed, followed
y reﬁnement in Cartesian space with explicit solvent. During thecs and Modelling 77 (2017) 311–321 315
ﬁnal step, the complex is immersed in a suitable solvent environ-
ment, using TIP3P water model [62]. Then, the models are subjected
to molecular dynamics simulation at 300 K [63]. Initially position
restraints are applied on the non-interface heavy atoms, which are
relaxed in later stages to facilitate side chain optimization [59–61].
Docking results obtained as ligand poses on different binding site
clusters based on positional interface ligand RMSD were individu-
ally inspected, after which high scoring models were passed into
the reﬁnement step.
2.4. Reﬁnement of docked complexes
The structures of CRIP1b in complex with the CB1-receptor C-
terminus 9-mer peptide (S464TDTSAEAL472) obtained from docking
results were subjected to FireDock (Fast Interaction REﬁnement in
molecular DOCKing) for rescoring and reﬁnement [64]. The rear-
rangement of the interface side-chains followed by adjustment of
the relative orientation of the molecules, are incorporated in the
reﬁnement process. The reﬁned structures are ranked according
to their binding energy, which is represented by global energy.
The atomic contact energy (ACE), van der Waals forces (Attrac-
tive and Repulsive VdW) and hydrogen bonds (HB) contribute to
the calculation of global energy, leading to ﬁnal ranking [64,65].
The best scoring complex was  further analyzed with PyMOL, Dis-
covery Studio and Protein Interactions Calculator (PIC) [66]. PIC
computes various interactions such as disulphide bonds, interac-
tions between hydrophobic residues, ionic interactions, hydrogen
bonds, aromatic–aromatic interactions, aromatic–sulphur inter-
actions and cation–  interactions within a protein or between
proteins in a complex [66].
3. Results and discussion
3.1. Model of 9-mer peptide (S464TDTSAEAL472) of CB1 receptor
C- terminus tail
A de novo approach using PEP-Fold server was used to calcu-
late the structure of the 9-mer peptide (S464TDTSAEAL472) (Fig. 2).
The PEP-Fold ranks generated models according to their sOPEP,
the coarse grained energy. The best-ranked model was  selected for
docking studies. The energy minimization of the selected peptide
was performed by Conjugate gradient protocol under CHARMM
force ﬁeld.
3.2. The CRIP1b models
The human CRIP1b sequence was  retrieved from NCBI with
accession NP 001104571. The CRIP1b sequence was  subjected to
secondary structure calculation. The consensus result of various
algorithms showed beta sheets as the major secondary structure
component (Fig. 3).
The Blastp results (Supporting ﬁle: Table S1) did not show any
suitable sequence homolog for the purposes of modeling structures.
Other tools were utilized for more sensitive data mining in search
of CRIP1b structural homologs. The results produced by PDBBLAST,
CSBLAST, COMA, Hhblits, HHSearch, FFAS and Phyre were low scor-
ing (Supporting ﬁle: Table S1 A-G). The SwissModel suggested RHO
GDP-DISSOCIATION INHIBITOR 2 (1DS6 B) [63] as a suitable tem-
plate for modeling with 27.5% identity with CRIP1b (Supporting
ﬁle: Table S2).This template was also recently suggested for CRIP1a
homolog by Ahmed and colleagues [21]. Because our goal was to
seek commonality or distinct differences from CRIP1a, we chose
to use this template. The RHO-GDI2 structure-CRIP1b sequence
alignment (Fig. 4) was  used as input for computing CRIP1b mod-
els, using Modeller (Discover studio), followed by loop reﬁnement
and energy minimization (Fig. 1A). Apart from homology modeling,
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Table 2
FireDock scores. The docked poses of CRIP1b in Complex with the CB1 9-mer peptide were reﬁned and ranked by their binding energy/global energy (kcal/mol), which were
contributed by attractive and repulsive Van der Waals (VdW) forces, atomic contact energy(ACE) and hydrogen bonds(HB).
Rank Solution Number Global Energy Attractive VdW Repulsive VdW ACE HB
1 11 −38.77 −17.43 3.72 −8.89 0.00
2  27 −38.19 −14.59 1.42 −10.07 0.00
3  12 −35.05 −17.69 4.42 −4.54 −1.16
4  34 −33.46 −20.68 6.30 −6.97 −1.47
5  19 −31.99 −19.96 8.32 −8.86 −1.61
6  26 −31.76 −20.19 3.95 −5.47 −2.04
7  8 −31.36 −18.81 7.90 −5.35 −3.84
8  2 −30.78 −19.25 8.78 −10.22 −3.06
9  35 −28.31 −17.35 5.69 −9.30 −0.50
10  10 −28.17 −18.47 4.22 −4.06 −2.22
11  7 −27.43 −14.61 1.10 −3.12 −2.64
12  17 −26.42 −18.67 5.56 −4.24 −1.82
13  29 −23.96 −12.25 4.14 −6.86 −1.10
14  6 −23.81 −19.43 4.94 −7.83 −2.44
15  23 −23.73 −20.79 6.42 −0.73 −4.38
16  30 −22.75 −15.15 3.61 −5.71 −1.67
17  36 −22.71 −14.68 7.75 −6.77 −1.41
18  1 −22.47 −12.56 6.79 −7.48 −1.82
19  37 −22.47 −12.56 6.79 −7.48 −1.82
20  21 −22.36 −16.79 6.70 −6.95 −1.72
21  15 −20.78 −13.24 3.74 −3.67 −0.36
22  24 −20.38 −12.79 2.14 −2.77 0.00
23  31 −18.24 −17.65 4.80 −2.24 −1.98
24  4 −16.62 −20.56 7.33 −3.08 −1.02
25  20 −16.41 −17.54 6.70 −5.84 0.00
26  9 −15.62 −14.81 0.66 −0.40 −1.69
27  32 −15.45 −11.91 0.75 −4.81 0.00
28  28 −14.71 −13.76 4.69 −3.96 −1.16
29  16 −14.07 −17.12 12.77 −2.34 −1.52
30  33 −12.81 −13.58 4.74 −2.54 −1.58
Table 3
Interactions between CRIP1b and the CB1 receptor C-terminus 9-mer peptide. The Chain A represents CRIP1b while chain B represents CB1-R peptide. The distances are
represented as Dd-a (between Donor and Acceptor) and Dh-a(between Hydrogen and Acceptor) while angles are represented as A(d-H N)(between Donor-H N) and
A(a  O C)(between Acceptor O C). The MO  stands for Multiple Occupancy. The undeﬁned values are indicated as “-“.
A. Binding pocket residues of CRIP1b within 4 Å of CB1 R – peptide
Position 64 68 77 79 82 85 86 124 126
Residue ILE LEU GLU ASP ARG TYR TYR TYR CYS
B.  Hydrophobic Interactions within 5 Å
Position Residue Chain Position Residue Chain
64 ILE A 472 LEU B
68  LEU A 469 ALA B
85  TYR A 469 ALA B
89  TYR A 472 LEU B
124  TYR A 469 ALA B
C.  Ionic Interactions within 6 Å
Position Residue Chain Position Residue Chain
82 ARG A 466 ASP B
D.  Protein–Protein Main Chain-Side Chain Hydrogen Bonds
Donor Acceptor Parameters
POS CHAIN RES ATOM POS CHAIN RES ATOM MO  Dd-a Dh-a A(d-H N) A(a O C)
77 A Glu OE1 465 B Thr O 1 3.35 2.70 119.29 172.19
77  A Glu OE1 465 B Thr O 2 3.35 3.43 76.62 172.19
82  A Arg NH1 465 B Thr O 1 2.50 3.13 45.15 133.79
82  A Arg NH1 465 B Thr O 2 2.50 2.33 87.44 133.79
82  A Arg NH2 465 B Thr O 1 2.82 3.58 37.22 122.79
82  A Arg NH2 465 B Thr O 2 2.82 2.65 88.58 122.79
85  A Tyr OH 468 B Ser O – 3.05 – – 87.81
124  A Tyr OH 469 B Ala O – 2.38 – – 135.51
126  A Cys SG 469 B Ala O – 2.98 – – 147.60
126  A Cys SG 470 B Glu O – 3.92 – – 101.32
126  A Cys SG 472 B Leu O – 2.30 – – 125.72
126  A Cys SG 472 B Leu OXT – 3.51 – – 64.40
464  B Ser N 124 A Tyr OH – 3.16 – 179.42 –
469  B Ala N 85 A Tyr OH – 3.27 3.97 39.03 –
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Fig. 6. Docked poses of CB1 receptor C terminus peptide on CRIP1b model.
Docking studies yielded various docked complexes with peptide on distinct positions. All the poses were reﬁned and scored. On the left side of ﬁgure, the colored spheres
show  the positions of peptide on CRIP1b in different poses. While on the right side, binding pockets of top scoring poses from three different clusters are written with
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ther approaches like ab-initio and threading were also employed
o obtain CRIP1b models. For comparison, we also calculated CRIP1a
odel, using the same template RHO-GDI 2.
.3. Selection of a valid model
Because multiple CRIP1b models were generated by different
pproaches, it was important to choose a valid model with the
est quality for further studies. For this purpose DOPE scores of all
he models were calculated to facilitate their ranking. One of the
RIP1b models generated by homology modeling (with RHO GDI 2
s template) showed the lowest DOPE value (Fig. 5). The ab initio
odels generated by Robetta were closest to, but not better than,
he models generated by Discovery studio in terms of their high
OPE score, (Table 1). The best ranking CRIP1b structure was vali-
ated with Ramachandran plot having all the residues in favorable
egion (Supporting ﬁle: Fig. S1). The secondary structure data was
lso in agreement with the CRIP1b model, showing a sandwich fold
odel with beta sheets.
Because CRIP1a and CRIP1b sequences are identical within the
nitial 110 residues, comparison between their models was  per-
ormed. Although the model of CRIP1a is already reported by
hmed et al. [21], the PDB coordinates of model are not available, so
e derived the CRIP1a model in the same manner as CRIP1b to draw
omparisons between the two. The residues lying in the C-terminal
egion (amino acids 155–164) were not covered by the template;
ence they were modeled by an ab initio approach using Robetta
nd incorporated to form a full length model of CRIP1a. The homol-
gy model (with RHO-GDI 2 as template) showed the best DOPE
cores; secondary structure data and Ramachandran Plot validated
t. CRIP1a also showed a sandwich fold model with beta sheets (Sup-
orting ﬁle: Fig. S2A). The CRIP1a and CRIP1b models were aligned
Supporting ﬁle: Fig. S2B), the majority of their secondary structure
s not only similar to each other, but also agrees with the CRIP1a
odel reported by Ahmed et al. [21]. The best ranked models ofted by oval background of different colors i.e.,  negative charged by pink, positive
terpretation of the references to colour in this ﬁgure legend, the reader is referred
CRIP1b as well as CRIP1a were chosen for further interaction studies
with the CB1 receptor C-terminus 9-mer peptide.
3.4. Molecular docking of CRIP1b with the CB1 receptor
C-terminus peptide
To study interactions between CRIP1b and CB1 receptor C-
terminus distal tail, the CRIP1b was docked with the 9-mer peptide
(S464TDTSAEAL472) model generated earlier. Here, we  have used
HADDOCK 2.2, which implements solvated docking approach along
with conventional Haddock docking protocol [67]. Each molecule
and its associated solvation shell are considered as rigid body,
due to which an encounter complex is formed with a water layer
between the two  protein chains (in our case CRIP1b and CB1R
peptide). The non-interfacial waters are removed and during subse-
quent energy minimization stage the remaining waters and protein
chains are treated are separate rigid bodies. Afterwards a biased
Monte Carlo procedure is applied to remove water molecules,
based on their probabilities for water-mediated contacts for spe-
ciﬁc amino acids. This procedure is repeated until only 25% of the
initial interfacial water molecules remain. During the ﬁnal steps,
water molecules are removed if their interaction energy is unfavor-
able. The interaction energy (sum of van der Waals and electrostatic
water–protein energies) should be less than 0.0 kcal/mol.
As the site where the C-terminus of CB1 binds exactly on CRIP1b
is not known, the 9-mer peptide was  docked with all possible sites
on CRIP1b. The Haddock analysis returned 36 poses, grouped in nine
clusters based on positional interface ligand RMSD. Twelve poses
from the top three clusters were scattered at different positions
on the CRIP1b surface (Fig. 6). The binding pockets of these three
clusters revealed the residues involved (Fig. 6). The CRIP1a model
was also docked with CB1 receptor C-terminus peptide (Supporting
ﬁle: Fig. S3).
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.5. Reﬁned poses of CRIP1b in complex with the CB1receptor
-terminus distal tail
All of the docked poses of CRIP1b were subjected to reﬁne-
ent, followed by binding energy (referred to as global energy
n Kcal/mol) calculation (Table 2). The best scoring reﬁned pose
f CRIP1b in complex with CB1 receptor C-terminus peptide was
aken into account for interaction analyses. The best scoring pose
or CRIP1a in complex with CB1 receptor C-terminus peptide was
etrieved under same set of parameters (Supporting ﬁle: Table S3).
he interactions for both complexes were calculated by PIC.
The last nine amino acids of the C-terminus of the CB1 recep-
or (Fig. 2) are mostly polar in nature. The polar interactions are
xpected to be the major interaction between CRIP1b and CB1
eceptor. Our model suggests that CRIP1b forms hydrophobic and
ydrogen bond interactions with the CB1 receptor C-terminus pep-
ide (Table 3). The hydrogen bonds involve Glu77, Arg82, Tyr85,
yr124, Cys126 from CRIP1b and Ser464, Thr465, Ser468, Ala469,
lu470, Leu472 from the CB1 receptor peptide (Fig. 7). Similarly
nteractions for CRIP1a with CB1receptor peptide were calculated
nd hydrophobic and hydrogen bond interactions were found (Sup-
orting ﬁle: Table S4). The residues, namely Ser63, Asp81, Val83,
yr 126, Tyr128, from CRIP1a were involved in the majority of inter-
ctions (Supporting ﬁle: Fig. S4). The binding pockets of CRIP1b and(magenta stick model).
icks; those involved in hydrogen bonds are connected to the CB1 receptor peptide
the reader is referred to the web version of this article.)
CRIP1a lies in similar region between residues 61 and 128, mainly
encompassing residues at position 82, 85 and 126. If we compare
the binding pockets within a 4 Å radius of the CB1 receptor peptide
in CRIP1a reported by Ahmed and colleagues [21] with our data,
a large number of common residues are observed. The residues at
position 64, 68, 82, 85, 124 and 126 lie in binding pockets of CRIP1b
as well as CRIP1a. This is in agreement with the model of CRIP1a
obtained by Ahmed et al. [21].
4. Conclusion
There are previous experimental data indicating CRIP1-CB1
receptor interactions [11]; however, due to the absence of crys-
tal/solution structures of the complex or CRIP1b protein, these
interactions have never been studied at the atomic level. For CRIP1
proteins, the majority of studies have been performed on CRIP1a
and the data on CRIP1b are very limited. Our study is the ﬁrst
attempt to study structure and interactions of CRIP1b with the CB1
receptor. To predict and ensure accurate three-dimensional mod-
els of CRIP1b structure, a number of different modeling techniques
(Ab initio, fold recognition and homology modeling using RHO-GDI
2 as a template) were incorporated. RhoGDI 2 is known to regulate
the GDP/GTP exchange reaction of Rho proteins by inhibiting the
dissociation of GDP and the subsequent binding of GTP  to them
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68,69]. The CB1 cannabinoid receptors promote focal adhesion
inase (FAK) activation, and data suggest that CB1-stimulated FAK
hosphorylation and activation can be mediated by G12/13 regu-
ation of Rac1 and RhoA [70]. Although we have data indicating a
ole for CRIP1a in the Gi/o family regulation, we have not explored
he interactions between CRIP proteins, the G12/13 proteins, and
he Rho family proteins. Rho-GDI 2 is characterized by a sandwich
old beta structure, and exhibits the best identity with CRIP1b. The
emplate (Rho-GDI 2) used for homology modeling by us is same as
he one used by Ahmed et al. [21], for CRIP1a studies (obtained by
hreading), but we obtained it from SwissModel template search
38]. The sequence alignment of Rho-GDI2 and CRIP1b encom-
assed all 128 residues of CRIP1b. Apart from homology models,
ther models obtained from different methods were also individ-
ally evaluated and ranked accordingly. The best scoring CRIP1b
odel (with Rho-GDI2 as a template) having a beta sandwich fold
alidated by Ramachandran Plot was selected for interaction stud-
es.enta). (For interpretation of the references to colour in this ﬁgure legend, the reader
b, while lower portion shows their respective binding pockets.
The 9-mer peptide (464STDTSAEAL472) from the CB1 receptor
distal C-terminus, was  modeled using PEPFOLD, and docked as a
ligand to the best-scored model of CRIP1b. The HADDOCK protocol
generates multiple poses based on energy and scoring functions.
These poses were further reﬁned and the best scoring pose in terms
of its interaction energy was chosen for interaction analysis. The
best scoring reﬁned model of CRIP1b in complex with the CB1
receptor C-terminus peptide showed favorable polar interactions.
Overall, the binding pocket of CRIP1b was found to be similar to
that of CRIP1a (Fig. 8). The Arg82 and Cys126 of CRIP1b, involved in
the majority of hydrogen bond interactions with the 9-mer peptide,
are possible key residues required for interactions between the CB1
receptor and CRIP1b. Though we didn’t see bonds with Lys130 as
described by Ahmed et al., but Lys130 exists in the binding pocket
of CRIP1a in our results(Supporting ﬁle: Table S4A). The presence
of Lys130 within the 4 Å radius of CB1R peptide indicates the high
possibility of contacts between Lys130 of CRIP1a and CB1R pep-
tide. Apart from Lys130, the other residues (Asn61, Ser63, Asp81,
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rg82, Tyr126 and Asn127) of CRIP1a overlap with binding pocket
eﬁned by Ahmed et al. [21], within the 4 Å radius of CB1R peptide.
he CRIP1a binding pocket deﬁned by us not only overlaps with
ata generated by Ahmed et al. [21], but also with CRIP1b binding
ites residues lying in region 64–126.
Our computational studies indicate that CRIP1b shares similar
B1 receptor binding pocket residues with CRIP1a, but there are
unctional differences between the two proteins. As it is known
hat CRIP1a (164 residues) and CRIP1b (128 residues) amino acid
equences are identical for the initial 110 residues, it can be postu-
ated that the remaining 54 residues of CRIP1a may  contribute to
ifferences in their function. CRIP1a signiﬁcantly attenuates tonic
nhibition of voltage-gated Ca2+ channels by the CB1receptor but
RIP1b does not. CRIP1a but not CRIP1b has a predicted palmitoy-
lation site that may  contribute to its localization at the plasma
embranes [11]. Also, CRIP1a but not CRIP1b contains a PDZ class
 ligand in its C-terminal tail, which could indicate a potential for
nteractions with proteins containing PDZ domains [11]. There is
o such ligand in the CRIP1b C-terminal tail, which could account
or the functional differences between CRIP1a and CRIP1b, in spite
f having similar CB1R interaction binding pocket.
As there were previously no experimental data available for
RIP1b structure, information obtained from our modeling studies
ay be used to guide design of future site directed mutagenesis
xperiments. Understanding structure and interactions of CRIP1
roteins will lead to understanding underlying mechanisms of reg-
lation of the CB1 receptor.
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